Chemiluminescence Immunoassay Segment is Anticipating to Grow The Market for Esoteric Testing Over The Forecast Period.

According to a new market research study titled ‘Esoteric Testing Market to 2025 – Global Analysis and Forecasts by Technology, Test Type, and End User’. The global esoteric testing market is expected to reach US$ 45,081.6 Mn in 2025 from US$ 19,868.2 in 2017. The market is estimated to grow with a CAGR of 11.7% from 2018-2025. The report highlights the trends prevalent in the global esoteric testing market and the factors driving the market along with those that act as deterrents to its growth.

Global esoteric testing market, based on technology was segmented into chemiluminescence immunoassay, real-time PCR, flow cytometry, mass spectrometry, enzyme-linked immunosorbent assay and others. In 2017, chemiluminescence immunoassay segment held the largest share of the market, by technology. Moreover, the chemiluminescence immunoassay segment held the largest share of the market owing to the advantages given by the tests which include wide dynamic range, high signal intensity, absence of interfering emissions (high specificity), rapid acquisition of the analytical signal, high stability of reagents and their conjugates, low consumption of reagents, random access, reduced incubation time and full compatibility with immunology assay protocols. However, the enzyme-linked immunosorbent assay segment is expected to grow at the fastest rate during the coming years.

The market for esoteric testing is expected to grow due to the increasing geriatric population & associated growth in chronic diseases, growing awareness regarding early detection using specific diagnostic tests and the rising prevalence of infectious diseases are likely to drive the market in the coming future. In addition, the growing awareness of personalized medicine is likely to have a positive impact on the growth of the market in the coming near future.

The major players operating in the genomics market include Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Sonic Healthcare, Caris Life Science, ACM Global Laboratories, Foundation Medicine, Inc., Miraca Holdings Inc., Agendia, Primary Health Care Limited and Rennova. For instance, in March, 2018, Agendia Announces CE Mark for NGS-Based MammaPrint BluePrint Kit for Breast Cancer Patients in Europe.

The report segments the global esoteric testing market as follows:

Global Esoteric Testing Market – By Technology

Chemiluminescence Immunoassay
Real time PCR
Flow Cytometry
Mass Spectrometry
Enzyme-Linked Immunosorbent Assay

Global Esoteric Testing Market – By Test Type

Infectious Diseases Testing
Oncology Testing
Genetic Testing
Neurology Testing
Endocrinology Testing

Global Esoteric Testing Market – By End User

Hospitals Laboratories
Independent & Reference Laboratories

Global Esoteric Testing Market – By Geography

North America


Asia Pacific (APAC)

Middle East & Africa (MEA)
South Africa
Saudi Arabia

South & Central America (SCAM)

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: